FDA Adverse Event
Malfunction
Summary report: N
COAGUCHEK S SYSTEM
MDR report key: 1771218
·
Received February 15, 2008
Report
- Report Number
- 1823260-2008-01613
- Event Type
- Malfunction
- Date Received
- February 15, 2008
- Date of Event
- February 5, 2008
- Report Date
- February 15, 2008
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JPA
- PMA / PMN Number
- K974569
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- NURSE
Narratives
Description of Event or Problem · 1
CALLER STATES THE PATIENT TESTED 2.2 INR ON THE COAGUCHEK S SYSTEM AND 1.7 INR ON A COMPARISON LAB. NO ACTION TAKEN ON DEVICE RESULT. COUMADIN WAS ADJUSTED BASED ON LAB RESULT. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT SYSTEM AND REPLACEMENT WAS SENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COAGUCHEK S SYSTEM | PROTHROMBIN TIME TEST STRIPS - JPA | JPA | ROCHE DIAGNOSTICS | 627A-D16 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 70 YR | LASIX - 20MG/DAY| SKELAXIN - 2400MG/DAY| ZYPREXA - 5MG/DAY| FERROUS SULFATE - 325MG/DAY| PREDNISONE - 10MG/DAY| DOCUSATE SODIUM| DIGOXIN - 0.25MG/DAY| FAMOTIDINE - 20MG/DAY| CYMBALTA - 30MG/DAY| OMEPRAZOLE - 40MG/DAY| MIRALAX - 17GRAMS/DAY| POTASSIUM CHLORIDE - 20 MILL EQUIVALENT/DAY| COUMADIN - 2MG/DAY |